Trento
In Trento province 72,4% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering local tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 8 cases of cervicocarcinoma and 4 related deaths and thus results to be cost-ef...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SEEd Medical Publishers
2008-09-01
|
| Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
| Subjects: | |
| Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1003 |
| _version_ | 1819153360731766784 |
|---|---|
| author | Maria Caterina Cavallo Filippo Cipriani Simone Gerzeli Nadia Demarteau Alessia Marocco Francesco Bamfi |
| author_facet | Maria Caterina Cavallo Filippo Cipriani Simone Gerzeli Nadia Demarteau Alessia Marocco Francesco Bamfi |
| author_sort | Maria Caterina Cavallo |
| collection | DOAJ |
| description | In Trento province 72,4% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering local tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 8 cases of cervicocarcinoma and 4 related deaths and thus results to be cost-effective (30.267 €/QALY). When the vaccination programme is extended to 16-year-old girls a further 8 cancer cases and 3 deaths could be prevented, with a very similar cost-effectiveness ratio. In Trento province, the net cost for woman vaccinated is 197 € for the single cohort and 199 € for the multiple cohort. |
| first_indexed | 2024-12-22T15:03:57Z |
| format | Article |
| id | doaj.art-7c0c97dd6242493bb4fa1bd20e77dd8e |
| institution | Directory Open Access Journal |
| issn | 2240-256X |
| language | English |
| last_indexed | 2024-12-22T15:03:57Z |
| publishDate | 2008-09-01 |
| publisher | SEEd Medical Publishers |
| record_format | Article |
| series | Farmeconomia: Health Economics and Therapeutic Pathways |
| spelling | doaj.art-7c0c97dd6242493bb4fa1bd20e77dd8e2022-12-21T18:22:03ZengSEEd Medical PublishersFarmeconomia: Health Economics and Therapeutic Pathways2240-256X2008-09-0191S272910.7175/fe.v9i1S.1003939TrentoMaria Caterina Cavallo0Filippo Cipriani1Simone Gerzeli2Nadia Demarteau3Alessia Marocco4Francesco Bamfi5Università Bocconi, MilanoGlaxoSmithKline Spa, VeronaDipartimento di Statistica ed Economia Applicate L. Lenti, Università di PaviaGlaxoSmithKline Biologicals, Wavre (Belgio)GlaxoSmithKline Spa, VeronaGlaxoSmithKline Spa, VeronaIn Trento province 72,4% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering local tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 8 cases of cervicocarcinoma and 4 related deaths and thus results to be cost-effective (30.267 €/QALY). When the vaccination programme is extended to 16-year-old girls a further 8 cancer cases and 3 deaths could be prevented, with a very similar cost-effectiveness ratio. In Trento province, the net cost for woman vaccinated is 197 € for the single cohort and 199 € for the multiple cohort.https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1003trentohpv vaccinationeconomic & clinical impact |
| spellingShingle | Maria Caterina Cavallo Filippo Cipriani Simone Gerzeli Nadia Demarteau Alessia Marocco Francesco Bamfi Trento Farmeconomia: Health Economics and Therapeutic Pathways trento hpv vaccination economic & clinical impact |
| title | Trento |
| title_full | Trento |
| title_fullStr | Trento |
| title_full_unstemmed | Trento |
| title_short | Trento |
| title_sort | trento |
| topic | trento hpv vaccination economic & clinical impact |
| url | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1003 |
| work_keys_str_mv | AT mariacaterinacavallo trento AT filippocipriani trento AT simonegerzeli trento AT nadiademarteau trento AT alessiamarocco trento AT francescobamfi trento |